Cytek Biosciences (CTKB)
NASDAQ:CTKB
Holding CTKB?
Track your performance easily

Cytek Biosciences (CTKB) Financial Statements

45 Followers

Cytek Biosciences Financial Overview

Cytek Biosciences's market cap is currently ―. The company's EPS TTM is $-0.077; its P/E ratio is -93.40; Cytek Biosciences is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $0.07. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 51.50M$ 46.62M$ 44.86M$ 58.23M$ 48.00M
Gross Profit$ 29.00M$ 25.44M$ 23.01M$ 33.05M$ 27.18M
EBIT$ 157.00K$ -7.19M$ -8.59M$ 4.50M$ -3.59M
EBITDA$ 1.72M$ -5.89M$ -7.33M$ 6.93M$ -1.03M
Net Income Common Stockholders$ 941.00K$ -10.43M$ -6.17M$ 5.50M$ -6.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 277.78M$ 277.21M$ 270.09M$ 262.41M$ 287.99M
Total Assets$ 491.23M$ 483.73M$ 492.07M$ 494.46M$ 519.43M
Total Debt$ 8.99M$ 9.44M$ 10.17M$ 11.13M$ 11.88M
Net Debt$ -268.79M$ -267.77M$ -259.91M$ -251.28M$ -276.12M
Total Liabilities$ 105.76M$ 94.60M$ 99.45M$ 101.39M$ 103.91M
Stockholders Equity$ 385.46M$ 389.12M$ 392.61M$ 393.06M$ 415.52M
Cash Flow-
Free Cash Flow$ 12.24M$ 5.08M$ 3.33M$ 7.95M$ -5.63M
Operating Cash Flow$ 13.22M$ 6.20M$ 3.96M$ 9.51M$ -4.24M
Investing Cash Flow$ -15.81M$ 2.02M$ -5.75M$ 29.07M$ 43.12M
Financing Cash Flow$ -12.08M$ -1.71M$ 1.61M$ -33.75M$ -8.27M
Currency in USD

Cytek Biosciences Earnings and Revenue History

Cytek Biosciences Debt to Assets

Cytek Biosciences Cash Flow

Cytek Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis